COVID, IVERMECTIN and VACCINE Information Full Feature Documentary

killagram

Rising Star
BGOL Investor
Merck, the company that owns Ivermectin, said it did not work for Covid. They do not make a Covid 19 vaccine. There's a reason that they don't want humans taking it. They know more than anyone about their own drug. The military injects soldier with all types of shit. But they don't use anything without FDA approval. The Covid 19 vaccine is now mandatory for all active military after FDA approval. There's no money in vaccines Bro. They are all damn near free.

No money in vaccines???? WHY was so many pharma guys made Millions last year? Why Is PHIZER...Rich as fuck now? Always remember... ABSOLUTELY NOTHING IN AMERIKKKA IS....FREE...JACKKKK
 

Mixd

Duppy Maker
BGOL Investor
But they free...but nobody makes money... kinsfolk :roflmao2:
And correction to my other post. Pfizer says they charge the gubment about $20 a dose.

BUT...

The gubment pays about $100+ per dose to vaccine facilities. But those pop up type places, some charge the govt about $140-180 per dose. Like the tent type places, and the mobile vans. They charge the govt the most.
 

Mixd

Duppy Maker
BGOL Investor
What is this? Brah
Biden administration to fund programs to hand out crack pipes

The U.S. Department of Health & Human Services is reportedly seeking to give grants to programs that hand out crack pipes to drug addicts as part of a program to keep drug users safe. The idea is to limit infections among drug users.
 

killagram

Rising Star
BGOL Investor
Biden administration to fund programs to hand out crack pipes

The U.S. Department of Health & Human Services is reportedly seeking to give grants to programs that hand out crack pipes to drug addicts as part of a program to keep drug users safe. The idea is to limit infections among drug users.

I need in on this..brah
 

Mixd

Duppy Maker
BGOL Investor
I need in on this..brah
Maybe I'll drop a book on how to cook the perfect rock.

50c8ae6bb4b15.image.jpg
 

Mrfreddygoodbud

Rising Star
BGOL Investor
Notice what she didnt mention...cough cough vit c, zinc, IVERMECTIN... notice what she did mention...


Bitch fractured her skull talkin bout jesus loves me the most.. I think thats a message

to her tribesmen...
 

xxxbishopxxx

Rising Star
BGOL Investor


Posts mislead on PCR test development
By JOSH KELETYtoday

CLAIM: COVID-19 PCR tests weren’t developed using samples of the coronavirus and instead detect “something else.”

AP’S ASSESSMENT: Partly false. A PCR test created by the Centers for Disease Control and Prevention at the beginning of the pandemic was developed with genetic sequencing of the coronavirus, rather than actual samples. But experts say that is a normal method, and the test was still designed to detect the virus and was proven effective in studies.

THE FACTS: Misleading posts circulating widely online in recent days are using technical documents from one COVID-19 PCR test to falsely claim that such tests don’t actually detect the coronavirus – with some users going so far as to suggest they instead pick up the common cold or flu.

“FDA document admits ‘Covid’ PCR test was developed without isolated samples for test calibration, effectively admitting it’s testing something else,” one Twitter user wrote in a Feb. 14 tweet that was shared over 12,000 times. The claim has also circulated on Facebook and Telegram.

To support the claim, social media users shared the “Instructions for Use” for the PCR, or polymerase chain reaction, COVID-19 test released by the CDC in early 2020, as the virus was first emerging in the U.S. The document notes that “no quantified virus isolates of the 2019-nCoV were available for CDC use at the time the test was developed.”

But the test is still accurate and was still developed to detect the coronavirus that causes COVID-19 – and not “something else” like the cold or flu, according to an expert and a spokesperson for the U.S. Food and Drug Administration.

The CDC test did not use an actual sample of the coronavirus because samples were unavailable at that early time in the pandemic. However, the agency instead relied on genetic sequencing of the virus to determine the test’s effectiveness, which is a common practice, according to Matthew Binnicker, director of the clinical virology lab at the Mayo Clinic in Rochester, Minnesota.

“During the initial days of an emerging disease outbreak, it may be difficult for public health laboratories (and diagnostic test manufacturers) to gain access to actual clinical samples from patients who are infected with a novel agent,” he wrote in an email to the AP. “This type of approach is not uncommon when a new diagnostic test needs to be rapidly developed during an outbreak of a novel pathogen, and it is scientifically accepted, robust, and legitimate.”

Binnicker added that the genetic sequence used to design the test was not the same sequence as other coronaviruses, such as the common cold. James McKinney, a spokesperson for the FDA, which authorizes PCR tests, concurred the cold virus was “never used as a substitute for SARS-CoV-2 in validation studies.”

“Although not isolated from clinical samples, the material used to analytically validate the test is representative of SARS-CoV-2, and demonstrates the ability of the test to detect SARS-CoV-2 in patient samples,” he wrote in an email to the AP.

As the AP has previously reported, tests authorized for emergency use in the U.S. must meet strict criteria for accuracy. In addition to studies demonstrating that the CDC test only detected the coronavirus, the test also underwent a clinical study “evaluating respiratory samples from patients suspected of COVID-19,” McKinney wrote.

McKinney noted that the document cited by social media users features a table showing that the test did not detect other respiratory pathogens.

Hundreds of different COVID-19 tests have since been authorized by the FDA, according to the agency’s website. And all that were authorized by the agency after May 2020 were “validated” with samples of the coronavirus, according to McKinney.

Meanwhile, the CDC announcedin July 2021 that it would “retire” the test being cited on social media in favor of newer tests that can detect multiple viruses, not just the coronavirus, the AP reported. The CDC did not respond to the AP’s request for comment.

___

This is part of AP’s effort to address widely shared misinformation, including work with outside companies and organizations to add factual context to misleading content that is circulating online. Learn more about fact-checking at AP.
 

xxxbishopxxx

Rising Star
BGOL Investor



Fact Check-Neither Justin Trudeau nor the Trudeau Foundation have shares in Acuitas Therapeutics
By Reuters Fact Check

7 MIN READ


Neither Canadian Prime Minister Justin Trudeau nor his family’s Pierre Elliott Trudeau Foundation have any shares in a Vancouver-based biotechnology company that produces a key component of Pfizer/BioNTech’s COVID-19 vaccine. The Prime Minister’s Office and two of the company’s founders told Reuters that a claim that they did, made during a podcast, is false.

Making the claim was Dr Robert Malone, a virologist and immunologist who has previously been fact-checked by Reuters (here), (here) and (here).

He suggested that Trudeau and his family’s charity own 40% of Acuitas Therapeutics, the company providing the lipid nanoparticle delivery system in Pfizer’s Comirnaty vaccine (here).

“There is, in Canada, quite a bit of speculation that Justin Trudeau and his family's foundation holds 40% of Acuitas,” Malone said during the broadcast. “Acuitas is the manufacturer of mechanic lipids that are used by Pfizer and the formulation technology. It’s privately held. So, there appears that there may be a major financial conflict of interest on the part of Mr Trudeau." The full ‘Tommy’s Podcast’ episode can be seen (here).

Asked how long he had “known” about the ownership issue, Dr Malone replied: “I have known that there was speculation that this might be the case. Remember, I know Pieter Cullis, the academic at the University of British Columbia that gave rise to Acuitas, that I’ve spoken to him over time, including over the last couple of years a couple of times, I’ve known him professionally for decades. He would not take my calls last night when I was seeking to verify this information about ownership so there are financial C.o.I. issues that are going to come to the fore; there are failure-to-disclose-risks issues that are going to come to the fore.”

Other versions of the clip can be found across multiple social media platforms, including on Twitter (here and here) where it has been retweeted more than 20,000 times, on Rumble (here) and on the Facebook profile of a Spanish-speaking account (here).



A similar claim made on Twitter (here), which has been retweeted more than 8,700 times, was also replied to by Randy Hillier, a Canadian politician who serves as a member of the Provincial Parliament in the Legislative Assembly of Ontario.


Hillier wrote in response that Trudeau “profits directly from every jab you take” (here).


Those tweets have been shared on Facebook in various iterations (here), (here) and (here).

However, there is no truth to the claims, according to the Prime Minister’s Office and two of the founders of Acuitas Therapeutics.

The Prime Minister’s Office (PMO) confirmed to Reuters that the claims were “not accurate” and said Public Office Holders must disclose information about financial interests to the Office of the Conflict of Interest and Ethics Commissioner (CIEC), which is published publicly online.

Acuitas co-founder Dr. Thomas Madden told Reuters via email: “Neither Prime Minister Justin Trudeau nor the Trudeau Foundation have any shares in or connection to Acuitas Therapeutics”. Fellow co-founder Dr. Pieter Cullis, who was specifically mentioned in the podcast, echoed Madden’s statement, adding that there was “no foundation” for the claims.

After being granted access to the company’s registry, Reuters did not see Trudeau or the Trudeau Foundation among those who were listed as having shares in Acuitas. A search for Acuitas on the CIEC public registry brought no results (here), (here), (here), (here), (here) and (here).

A summary of Trudeau’s profile on the CIEC’s Public Registry can be seen (here).

The PMO added that Trudeau has no ties to the Trudeau Foundation. They pointed to a CBC News article (here), where the prime minister was reported as saying: “I have not been in any way associated formally, or informally, with Pierre Elliott Trudeau Foundation in many, many, years. I stepped down from any of my family-related responsibilities shortly after having gotten elected, in order to demonstrate that there is a tremendous separation there."

The Trudeau Foundation’s most recent annual report can be seen (here).

VERDICT
False. Claims that Justin Trudeau and the Trudeau Foundation own 40% of shares in Acuitas Therapeutics are baseless, according to the Prime Minister’s Office and two of the founders of Acuitas.

This article was produced by the Reuters Fact Check team. Read more about our fact-checking work here .

Our Standards: The Thomson Reuters Trust Principles.
 

mangobob79

Rising Star
BGOL Investor


Posts mislead on PCR test development
By JOSH KELETYtoday

CLAIM: COVID-19 PCR tests weren’t developed using samples of the coronavirus and instead detect “something else.”

AP’S ASSESSMENT: Partly false. A PCR test created by the Centers for Disease Control and Prevention at the beginning of the pandemic was developed with genetic sequencing of the coronavirus, rather than actual samples. But experts say that is a normal method, and the test was still designed to detect the virus and was proven effective in studies.

THE FACTS: Misleading posts circulating widely online in recent days are using technical documents from one COVID-19 PCR test to falsely claim that such tests don’t actually detect the coronavirus – with some users going so far as to suggest they instead pick up the common cold or flu.

“FDA document admits ‘Covid’ PCR test was developed without isolated samples for test calibration, effectively admitting it’s testing something else,” one Twitter user wrote in a Feb. 14 tweet that was shared over 12,000 times. The claim has also circulated on Facebook and Telegram.

To support the claim, social media users shared the “Instructions for Use” for the PCR, or polymerase chain reaction, COVID-19 test released by the CDC in early 2020, as the virus was first emerging in the U.S. The document notes that “no quantified virus isolates of the 2019-nCoV were available for CDC use at the time the test was developed.”

But the test is still accurate and was still developed to detect the coronavirus that causes COVID-19 – and not “something else” like the cold or flu, according to an expert and a spokesperson for the U.S. Food and Drug Administration.

The CDC test did not use an actual sample of the coronavirus because samples were unavailable at that early time in the pandemic. However, the agency instead relied on genetic sequencing of the virus to determine the test’s effectiveness, which is a common practice, according to Matthew Binnicker, director of the clinical virology lab at the Mayo Clinic in Rochester, Minnesota.

“During the initial days of an emerging disease outbreak, it may be difficult for public health laboratories (and diagnostic test manufacturers) to gain access to actual clinical samples from patients who are infected with a novel agent,” he wrote in an email to the AP. “This type of approach is not uncommon when a new diagnostic test needs to be rapidly developed during an outbreak of a novel pathogen, and it is scientifically accepted, robust, and legitimate.”

Binnicker added that the genetic sequence used to design the test was not the same sequence as other coronaviruses, such as the common cold. James McKinney, a spokesperson for the FDA, which authorizes PCR tests, concurred the cold virus was “never used as a substitute for SARS-CoV-2 in validation studies.”

“Although not isolated from clinical samples, the material used to analytically validate the test is representative of SARS-CoV-2, and demonstrates the ability of the test to detect SARS-CoV-2 in patient samples,” he wrote in an email to the AP.

As the AP has previously reported, tests authorized for emergency use in the U.S. must meet strict criteria for accuracy. In addition to studies demonstrating that the CDC test only detected the coronavirus, the test also underwent a clinical study “evaluating respiratory samples from patients suspected of COVID-19,” McKinney wrote.

McKinney noted that the document cited by social media users features a table showing that the test did not detect other respiratory pathogens.

Hundreds of different COVID-19 tests have since been authorized by the FDA, according to the agency’s website. And all that were authorized by the agency after May 2020 were “validated” with samples of the coronavirus, according to McKinney.

Meanwhile, the CDC announcedin July 2021 that it would “retire” the test being cited on social media in favor of newer tests that can detect multiple viruses, not just the coronavirus, the AP reported. The CDC did not respond to the AP’s request for comment.

___

This is part of AP’s effort to address widely shared misinformation, including work with outside companies and organizations to add factual context to misleading content that is circulating online. Learn more about fact-checking at AP.

Fact Check-Neither Justin Trudeau nor the Trudeau Foundation have shares in Acuitas Therapeutics
By Reuters Fact Check

7 MIN READ


Neither Canadian Prime Minister Justin Trudeau nor his family’s Pierre Elliott Trudeau Foundation have any shares in a Vancouver-based biotechnology company that produces a key component of Pfizer/BioNTech’s COVID-19 vaccine. The Prime Minister’s Office and two of the company’s founders told Reuters that a claim that they did, made during a podcast, is false.

Making the claim was Dr Robert Malone, a virologist and immunologist who has previously been fact-checked by Reuters (here), (here) and (here).

He suggested that Trudeau and his family’s charity own 40% of Acuitas Therapeutics, the company providing the lipid nanoparticle delivery system in Pfizer’s Comirnaty vaccine (here).

“There is, in Canada, quite a bit of speculation that Justin Trudeau and his family's foundation holds 40% of Acuitas,” Malone said during the broadcast. “Acuitas is the manufacturer of mechanic lipids that are used by Pfizer and the formulation technology. It’s privately held. So, there appears that there may be a major financial conflict of interest on the part of Mr Trudeau." The full ‘Tommy’s Podcast’ episode can be seen (here).

Asked how long he had “known” about the ownership issue, Dr Malone replied: “I have known that there was speculation that this might be the case. Remember, I know Pieter Cullis, the academic at the University of British Columbia that gave rise to Acuitas, that I’ve spoken to him over time, including over the last couple of years a couple of times, I’ve known him professionally for decades. He would not take my calls last night when I was seeking to verify this information about ownership so there are financial C.o.I. issues that are going to come to the fore; there are failure-to-disclose-risks issues that are going to come to the fore.”

Other versions of the clip can be found across multiple social media platforms, including on Twitter (here and here) where it has been retweeted more than 20,000 times, on Rumble (here) and on the Facebook profile of a Spanish-speaking account (here).



A similar claim made on Twitter (here), which has been retweeted more than 8,700 times, was also replied to by Randy Hillier, a Canadian politician who serves as a member of the Provincial Parliament in the Legislative Assembly of Ontario.


Hillier wrote in response that Trudeau “profits directly from every jab you take” (here).


Those tweets have been shared on Facebook in various iterations (here), (here) and (here).

However, there is no truth to the claims, according to the Prime Minister’s Office and two of the founders of Acuitas Therapeutics.

The Prime Minister’s Office (PMO) confirmed to Reuters that the claims were “not accurate” and said Public Office Holders must disclose information about financial interests to the Office of the Conflict of Interest and Ethics Commissioner (CIEC), which is published publicly online.

Acuitas co-founder Dr. Thomas Madden told Reuters via email: “Neither Prime Minister Justin Trudeau nor the Trudeau Foundation have any shares in or connection to Acuitas Therapeutics”. Fellow co-founder Dr. Pieter Cullis, who was specifically mentioned in the podcast, echoed Madden’s statement, adding that there was “no foundation” for the claims.

After being granted access to the company’s registry, Reuters did not see Trudeau or the Trudeau Foundation among those who were listed as having shares in Acuitas. A search for Acuitas on the CIEC public registry brought no results (here), (here), (here), (here), (here) and (here).

A summary of Trudeau’s profile on the CIEC’s Public Registry can be seen (here).

The PMO added that Trudeau has no ties to the Trudeau Foundation. They pointed to a CBC News article (here), where the prime minister was reported as saying: “I have not been in any way associated formally, or informally, with Pierre Elliott Trudeau Foundation in many, many, years. I stepped down from any of my family-related responsibilities shortly after having gotten elected, in order to demonstrate that there is a tremendous separation there."

The Trudeau Foundation’s most recent annual report can be seen (here).

VERDICT
False. Claims that Justin Trudeau and the Trudeau Foundation own 40% of shares in Acuitas Therapeutics are baseless, according to the Prime Minister’s Office and two of the founders of Acuitas.

This article was produced by the Reuters Fact Check team. Read more about our fact-checking work here .

Our Standards: The Thomson Reuters Trust Principles.

Bing Bong !! back to back !! :roflmao: :roflmao: :roflmao:
 

xxxbishopxxx

Rising Star
BGOL Investor


This appointment happened 8 years ago. So between then and now has anyone called out reuters for any wrongdoing or misinformation? Although I can't say it's impossible, news services like AP and Reuters would destroy their businesses if any of them got caught purposely reporting something that is not true for economic gain.

For context, you have Rupert Murdoch who owns fox, who also owns the Wall Street Journal. The Wall Street Journal is still one of the most respected business info sources around, even though his Fox News stations are quite controversial and have been proven to constantly spread misinformation for economic gain.
 

xxxbishopxxx

Rising Star
BGOL Investor

If you read his profile, he is no longer the Chairman of Thomson/Reuters (not sure when he left that position). He's on the board of trustees for their charity service which is a separate thing from its actual news division, as far as I can tell.

 

Mixd

Duppy Maker
BGOL Investor
If you read his profile, he is no longer the Chairman of Thomson/Reuters (not sure when he left that position). He's on the board of trustees for their charity service which is a separate thing from its actual news division, as far as I can tell.

He was the CEO not chairman and he left at the start of Covid in Feb/Mar of 2020

 

Mixd

Duppy Maker
BGOL Investor
...and is currently still on the Pfizer board which is a conflict of interest that should be disclosed on every Reuters covid "fact check"
All these "fact checkers" are BS as clearly shown how Facebook/Instagram and many other social media are hiring these companies to censor and aren't even based in the US.

There's an agenda. But let people believe what they want.
 

xxxbishopxxx

Rising Star
BGOL Investor
All these "fact checkers" are BS as clearly shown how Facebook/Instagram and many other social media are hiring these companies to censor and aren't even based in the US.

There's an agenda. But let people believe what they want.
So what exactly did I post was untrue?
 
Top